[Lentigo maligna treated with 5% imiquimod cream]. / Lentigo maligno tratado con crema de imiquimod al 5%
Actas Dermosifiliogr
; 96(10): 700-2, 2005 Dec.
Article
em Es
| MEDLINE
| ID: mdl-16476324
ABSTRACT
Lentigo maligna (LM) is considered to be an in-situ stage of lentigo maligna melanoma. Clinically, it presents as a pigmented macule, irregular in shape and tone. 30% to 35% of untreated lentigo malignas can progress into lentigo maligna melanoma. The treatment of choice for this pathology is surgical excision with margins of 0.5 cm. of clinically normal skin around the lesion, or Mohs microsurgery. Imiquimod is a topical immunomodulator that stimulates both acquired and innate immunity. We present the case of a patient with LM, treated with 5% imiquimod cream, with an excellent therapeutic response.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Neoplasias Faciais
/
Sarda Melanótica de Hutchinson
/
Aminoquinolinas
/
Antineoplásicos
Limite:
Female
/
Humans
/
Middle aged
Idioma:
Es
Revista:
Actas Dermosifiliogr
Ano de publicação:
2005
Tipo de documento:
Article
País de afiliação:
Espanha